Q3 2024 Earnings Call Transcript February 12, 2025 Courtside Group, Inc. Common Stock misses on earnings expectations. Reported EPS is $-0.06452 EPS, expectations were $-0.05. Operator: Welcome to the ...

Scott Ulm; Co-Chief Executive Officer, Co-Vice Chairman of the Board and Head of Risk Management; ARMOUR Residential REIT Inc Gordon Harper; Chief Financial Officer, Controller, Company Secretary; ...

Q4 2024 Earnings Call Feb 13, 2025, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.

The LSEG U.S. Retail and Restaurant Q4 earnings index, which tracks changes in the growth rate of earnings within the sector, ...

HighlightsSales increased 2% to $10.6 billion, in-line with global light vehicle productionDiluted earnings per share of ...

Archer-Daniels-Midland offers value with a 4.4% dividend yield, growth initiatives, and cost-cutting strategies. See why we ...

In Q4 of 2024, Article 8 funds netted an estimated EUR 51.9 billion of net new money, the highest inflows of the year, supported by increased subscriptions into fixed-income funds. This report ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full year ...

Financial results at 31 December 2024 Strong 2024 results, 2025 Organic Cash Flow target raised Orange is accelerating the implementation of its Lead the Future ...

Aytu BioPharma reported a decrease in net revenue for Q2 2025, reflecting challenges in its ADHD portfolio. Despite this, the company posted a net income of $800,000, translating to $0.13 per share.